SLAM BioTherapeutics, Inc.

CIK 1983523 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for SLAM BioTherapeutics, Inc..

Recent SEC filings

FiledFormAccession number
Dec 29, 2025D0001983523-25-000004
Mar 3, 2025D0002014118-25-000002
Nov 13, 2023D0001983523-23-000001